{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:37:45Z","timestamp":1777419465135,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1124\/dmd.115.065748","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T01:43:13Z","timestamp":1442281393000},"page":"1847-1854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Organic Anion Transporter 1 Is Inhibited by Multiple Mechanisms and Shows a Transport Mode Independent of Exchange"],"prefix":"10.1016","volume":"43","author":[{"given":"Adam G.","family":"Hotchkiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiandai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"Berrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Ingraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M.","family":"Pelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.115.065748_bib1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1124\/dmd.110.032268","article-title":"Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin","volume":"38","author":"Amundsen","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.065748_bib2","doi-asserted-by":"crossref","first-page":"F378","DOI":"10.1152\/ajprenal.00735.2010","article-title":"Differences in the substrate binding regions of renal organic anion transporters 1 (OAT1) and 3 (OAT3)","volume":"301","author":"Astorga","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/dmd.115.065748_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/jpet.105.093070","article-title":"The impact of plasma protein binding on the renal transport of organic anions","volume":"316","author":"Bow","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.065748_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by organic anion transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.115.065748_bib5","series-title":"Guidance for Industry: Drug Interaction Studies\u2014Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations","year":"2012"},{"key":"10.1124\/dmd.115.065748_bib6","series-title":"Guideline on the Investigation of Drug Interactions","year":"2012"},{"key":"10.1124\/dmd.115.065748_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0005-2736(87)90444-5","article-title":"p-Aminohippurate transport in basal-lateral membrane vesicles from rabbit renal cortex: stimulation by pH and sodium gradients","volume":"897","author":"Eveloff","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.115.065748_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.115.065748_bib9","doi-asserted-by":"crossref","first-page":"F56","DOI":"10.1152\/ajprenal.00486.2012","article-title":"Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2","volume":"304","author":"Harper","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/dmd.115.065748_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/mol.114.091777","article-title":"A plasma concentration of \u03b1-ketoglutarate influences the kinetic interaction of ligands with organic anion transporter 1","volume":"86","author":"Ingraham","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.115.065748_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-59745-324-0_9","article-title":"Permeabilization of cell membranes","volume":"588","author":"Jamur","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.115.065748_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.115.065748_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.115.065748_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrm955","article-title":"The significance of molecular slips in transport systems","volume":"3","author":"Nelson","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/dmd.115.065748_bib15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cphy.c100084","article-title":"Renal transport of organic anions and cations","volume":"1","author":"Pelis","year":"2011","journal-title":"Compr Physiol"},{"key":"10.1124\/dmd.115.065748_bib16","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1124\/dmd.108.020750","article-title":"Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model","volume":"36","author":"Poirier","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.065748_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.115.065748_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11095-007-9401-6","article-title":"Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers","volume":"25","author":"Sato","year":"2008","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.115.065748_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00374173","article-title":"Modulation by anions of p-aminohippurate transport in bovine renal basolateral membrane vesicles","volume":"425","author":"Schmitt","year":"1993","journal-title":"Pflugers Arch"},{"key":"10.1124\/dmd.115.065748_bib20","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1002\/jps.23477","article-title":"Long-lasting inhibitory effects of saquinavir and ritonavir on OATP1B1-mediated uptake","volume":"102","author":"Shitara","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.115.065748_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/147323000002800401","article-title":"Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients","volume":"28","author":"Stangier","year":"2000","journal-title":"J Int Med Res"},{"key":"10.1124\/dmd.115.065748_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1751-7176.2011.00518.x","article-title":"Angiotensin receptor blockers: pharmacology, efficacy, and safety","volume":"13","author":"Taylor","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1124\/dmd.115.065748_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.693","article-title":"Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology","volume":"31","author":"VanWert","year":"2010","journal-title":"Biopharm Drug Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624102371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624102371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.115.065748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:25:24Z","timestamp":1739906724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624102371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0090955624102371"],"URL":"https:\/\/doi.org\/10.1124\/dmd.115.065748","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organic Anion Transporter 1 Is Inhibited by Multiple Mechanisms and Shows a Transport Mode Independent of Exchange","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.115.065748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}